Dry Needling Policy Number: PG0465 ADVANTAGE | ELITE | HMO Last Review: 07/26/2021

Total Page:16

File Type:pdf, Size:1020Kb

Load more

Dry Needling Policy Number: PG0465 ADVANTAGE | ELITE | HMO Last Review: 07/26/2021 INDIVIDUAL MARKETPLACE | PROMEDICA MEDICARE PLAN | PPO GUIDELINES This policy does not certify benefits or authorization of benefits, which is designated by each individual policyholder terms, conditions, exclusions and limitations contract. It does not constitute a contract or guarantee regarding coverage or reimbursement/payment. Self-Insured group specific policy will supersede this general policy when group supplementary plan document or individual plan decision directs otherwise. Paramount applies coding edits to all medical claims through coding logic software to evaluate the accuracy and adherence to accepted national standards. This medical policy is solely for guiding medical necessity and explaining correct procedure reporting used to assist in making coverage decisions and administering benefits. SCOPE X Professional X Facility DESCRIPTION Dry needling refers to a procedure in which a thin filiform needle is inserted into the skin and muscle at a site of myofascial pain. The physiological basis for dry needling depends on the targeted tissue and treatment objectives. The intent is to stimulate underlying myofascial trigger points, muscular, and connective tissues for the management of neuromusculoskeletal pain and movement impairments. Deep dry needling is believed to inactivate trigger points by eliciting contraction and subsequent relaxation of the taut band via a spinal cord reflex. Superficial dry needling is thought to activate mechanoreceptors and have an indirect effect on pain by inhibiting C-fiber pain impulses. Dry needling is not to be confused with traditional Chinese acupuncture, even though it does make use of acupuncture-type needles. Acupuncture follows the principles of energy flow as a guide to where the needles will be inserted; in dry needling, Needles are inserted directly into a myofascial trigger point, in an attempt to inactivate it, thereby decreasing the associated pain. Trigger points are discrete, focal, hyperirritable spots within a taut band of skeletal muscle fibers that produce local and/or referred pain when stimulated. Dry needling, even though it targets a trigger point, also differs from a trigger point injection, as there is no injection of medication or fluid. There is preliminary evidence that dry needling of trigger points is effective for short-term pain relief, and to improve quality of life and range of motion when compared to a placebo. However, further studies of high quality and with a standardized needling procedure are needed to support any health outcomes or benefits associated with this procedure. POLICY HMO, PPO, Individual Marketplace Dry needling is considered investigational for all applications. Dry needle trigger point injections (CPT 20560, 20561) for Commercial and Medicaid members are not considered medically necessary due to insufficient evidence of therapeutic value. Advantage Effective 7/1/2021 procedures 20560 and 20561 are covered, per The Ohio Department of Medicaid, for medically indicated services. PG0465 – 07/26/2021 Elite/ProMedica Medicare Plan Effective 6/1/2021 Paramount will cover acupuncture dry needling for Elite/ProMedica Medicare Plan Members with chronic lower back pain within specific guidelines in accordance with Medical Policy PG0382 Acupuncture. All other indications for dry needling is noncovered due to insufficient evidence of therapeutic value, including but not all-inclusive; dry needle trigger point injections. COVERAGE CRITERIA HMO, PPO, Individual Marketplace Paramount considers dry needling for trigger points (i.e., needle insertion without injection) experimental/investigational, as it is not identified as widely used and generally accepted. Although there are ongoing studies, there is little scientifically based data that their use results in improved patient outcomes in the medical literature. Advantage While there is insufficient evidence in the published medical literature to demonstrate the safety, efficacy and long- term outcomes of dry needling injections, The Ohio Department of Medicaid requires coverage for medically indicated services. Elite/ProMedica Medicare Plan Effective 6/1/2021 Dry Needling is covered for Elite/ProMedica Medicare Plan Members per coverage criteria documented in Medical Policy PG0382 Acupuncture: Refer to Medical Policy PG0382 Acupuncture. Diagnosis M54.5 Low Back Pain HMO, PPO, Individual Marketplace, Elite/ProMedica Medicare Plan, Advantage Dry Needling is additionally addressed in Medical Policies: PG0354 Intervention Pain Management Injection PG0432 Temporomandibular Joint Disorders PG0150 Chiropractic Services & Spinal Manipulation Alternative nonpharmacological treatment modalities for trigger point pain include manual techniques, massage, acupressure, ultrasonography, application of heat or ice, diathermy, transcutaneous electrical nerve stimulation, and spray cooling with manual stretch. CODING/BILLING INFORMATION The inclusion or exclusion of a code in this section does not necessarily indicate coverage. Codes referenced in this clinical policy are for informational purposes only. Codes that are covered may have selection criteria that must be met. Payment for supplies may be included in payment for other services rendered. CPT CODES 20560 Needle insertion(s) without injection(s); 1 or 2 muscle(s) 20561 Needle insertion(s) without injection(s); 3 or more muscle(s) 20999 Unlisted procedure, musculoskeletal system, general. (when utilized for dry needling) Because dry needling is not acupuncture, CPT codes 97810-97814 are not appropriate. Paramount reserves the right to review and revise our policies periodically when necessary. When there is an update, we will publish the most current policy to https://www.paramounthealthcare.com/services/providers/medical-policies/ . REVISION HISTORY EXPLANATION ORIGINAL DATE: 02/01/2020 PG0465 – 07/26/2021 Date Explanation & Changes 12/08/2020 Medical Policy placed on the new Paramount Medical Policy Format Updated Medical Policy to allow coverage for Dry Needling for Elite/ProMedica Medicare Plan Members with chronic lower back pain within specific guidelines in accordance with Medical Policy PG0382 Acupuncture. Per CMS: “...all types of acupuncture including dry 04/26/2021 needling for any condition other than chronic low back pain are non-covered by Medicare. Medicare will cover acupuncture for Medicare patients with chronic lower back pain within specific guidelines in accordance with NCD 30.3.3”. Effective 07/01/2021 procedures 20560 and 20561 are covered per the ODM Appendix DD fee 07/26/2021 schedule and the EAPG fee schedule, no prior authorization required. REFERENCES/RESOURCES Centers for Medicare and Medicaid Services, CMS Manual System and other CMS publications and services Ohio Department of Medicaid American Medical Association, Current Procedural Terminology (CPT®) and associated publications and services Centers for Medicare and Medicaid Services, Healthcare Common Procedure Coding System, HCPCS Release and Code Sets U.S. Preventive Services Task Force, http://www.uspreventiveservicestaskforce.org/ Industry Standard Review Hayes, Inc. Industry Standard Review PG0465 – 07/26/2021 .
Recommended publications
  • Dry Needle Stimulation of Myofascial Trigger Points Evokes Segmental Anti-Nociceptive Effects

    Dry Needle Stimulation of Myofascial Trigger Points Evokes Segmental Anti-Nociceptive Effects

    J Rehabil Med 2010; 42: 463–468 ORIGINAL REPORT DRY NEEDLE STIMULATION OF MYOFASCIAL TRIGGER POINTS EVOKES SEGMENTAL ANTI-NOCICEPTIVE EFFECTS John Z. Srbely, DC, PhD1, James P. Dickey, PhD2, David Lee, DC3 and Mark Lowerison, BSc, MSc4 From the 1Human Health and Nutritional Sciences, University of Guelph, Guelph, Ontario, 2School of Kinesiology, Univer sity of Western Ontario, London, 3Clinical Education, Canadian Memorial Chiropractic College, Toronto, and 4Centre for the Genetic Improvement of Livestock, University of Guelph, Guelph, Ontario, Canada Objective: To test the hypothesis that dry needle stimulation lifetime (1). Myofascial pain is one of the most common of a myofascial trigger point (sensitive locus) evokes segmen- examples of musculoskeletal pain; an accumulating body tal anti-nociceptive effects. of evidence suggests that unique hypersensitive loci, named Design: Double-blind randomized controlled trial. myofascial trigger points in the literature, are intimately as- Subjects: Forty subjects (21 males, 19 females). sociated with the pathophysiology and clinical manifestation Methods: Test subjects received intramuscular dry needle of myofascial pain (2). puncture to a right supraspinatus trigger point (C4,5); con- Trigger point injections with local anesthetics have been trols received sham intramuscular dry needle puncture. performed to alleviate musculoskeletal pain since the early Pain pressure threshold (PPT) readings were recorded from 1930s. No significant differences in subjective pain have been right infraspinatus (C ) and right gluteus medius (L S ) 5,6 4,5 1 reported when comparing the effects of lidocaine injection with trigger points at 0 (pre-needling baseline), 1, 3, 5, 10 and 15 dry needle stimulation of trigger points (3), suggesting that the min post-needling and normalized to baseline values.
  • Dry Needling in the Management of Musculoskeletal Pain

    Dry Needling in the Management of Musculoskeletal Pain

    J Am Board Fam Med: first published as 10.3122/jabfm.2010.05.090296 on 7 September 2010. Downloaded from CLINICAL REVIEW Dry Needling in the Management of Musculoskeletal Pain Leonid Kalichman, PT, PhD, and Simon Vulfsons, MD Myofascial pain is a common syndrome seen by family practitioners worldwide. It can affect up to 10% of the adult population and can account for acute and chronic pain complaints. In this clinical narrative review we have attempted to introduce dry needling, a relatively new method for the management of musculoskeletal pain, to the general medical community. Different methods of dry needling, its effec- tiveness, and physiologic and adverse effects are discussed. Dry needling is a treatment modality that is minimally invasive, cheap, easy to learn with appropriate training, and carries a low risk. Its effective- ness has been confirmed in numerous studies and 2 comprehensive systematic reviews. The deep method of dry needling has been shown to be more effective than the superficial one for the treatment of pain associated with myofascial trigger points. However, over areas with potential risk of significant adverse events, such as lungs and large blood vessels, we suggest using the superficial technique, which has also been shown to be effective, albeit to a lesser extent. Additional studies are needed to evaluate the effectiveness of dry needling. There also is a great need for further investigation into the development of pain at myofascial trigger points. (J Am Board Fam Med 2010;23:640–646.) Keywords: Dry-needling, Myofascial Trigger Points, Pain, Connective Tissue, Musculoskeletal, Alternative Medicine copyright.
  • Effectiveness of Acupuncture/Dry Needling for Myofascial Trigger Point Pain

    Effectiveness of Acupuncture/Dry Needling for Myofascial Trigger Point Pain

    Systematic Review Effectiveness of acupuncture/dry needling for myofascial trigger point pain Elizabeth A. Tough, Adrian R. White Peninsula Medical School, University of Exeter, UK Background: Myofascial trigger points (MTrPs) are widely accepted by clinicians and researchers as a primary source of pain. Needling is one common treatment, with dry needling as effective as injection. What is not clear is whether or not needling of any kind is superior to placebo. Objectives: To update a systematic literature review and meta-analysis (undertaken in 2007) investigating the effectiveness of direct MTrPs needling compared with placebo, and to discuss the variation in needling approaches adopted by randomized controlled trials (RCTs) investigating acupuncture/dry needling for MTrP pain. Methods: An electronic database search of RCTs published since the original review and a critical review of the literature. Results: Three RCTs of direct MTrP needling were identified as eligible for review. One concluded that needling was superior to standard care; two adopted a placebo control and were added to our original meta-analysis of four studies. Combining six studies (n5183), needling was found to be statistically superior to placebo [weighted mean difference516.67 (95% CI: 3.23–30.11)]; however, marked statistical heterogeneity was observed (I2582.6%). Conclusion: There is limited evidence that direct MTrP dry needling has an overall treatment effect when compared with standard care. While the results of the meta-analysis indicate that direct needling is superior to placebo, the results should be interpreted with caution due to the marked heterogeneity observed in this model. There remains a need for large-scale, adequately powered, high-quality placebo-controlled trials to provide a more trustworthy result.
  • Acupuncture and Dry Needling in the Management of Myofascial Trigger Point Pain: a Systematic Review and Meta-Analysis of Randomised Controlled Trials

    Acupuncture and Dry Needling in the Management of Myofascial Trigger Point Pain: a Systematic Review and Meta-Analysis of Randomised Controlled Trials

    European Journal of Pain 13 (2009) 3–10 Contents lists available at ScienceDirect European Journal of Pain journal homepage: www.EuropeanJournalPain.com Review Acupuncture and dry needling in the management of myofascial trigger point pain: A systematic review and meta-analysis of randomised controlled trials Elizabeth A. Tough a,*, Adrian R. White a, T. Michael Cummings b, Suzanne H. Richards a, John L. Campbell a a Primary Care, Peninsula Medical School, Universities of Exeter and Plymouth, Room N32, ITTC Building, Tamar Science Park, Plymouth PL6 8BX, UK b British Medical Acupuncture Society, Royal London Homeopathic Hospital, UK article info abstract Article history: Pain from myofascial trigger points is often treated by needling, with or without injection, although evi- Received 24 October 2007 dence is inconclusive on whether this is effective. We aimed to review the current evidence on needling Received in revised form 17 January 2008 without injection, by conducting a systematic literature review. Accepted 19 February 2008 We searched electronic databases to identify relevant randomised controlled trials, and included stud- Available online 18 April 2008 ies where at least one group were treated by needling directly into the myofascial trigger points, and where the control was either no treatment, or usual care; indirect local dry needling or some form of pla- Keywords: cebo intervention. We extracted data on pain, using VAS scores as the standard. Acupuncture Seven studies were included. One study concluded that direct dry needling was superior to no interven- Myofascial trigger point pain Systematic review tion. Two studies, comparing direct dry needling to needling elsewhere in the muscle, produced contra- Randomised controlled trials dictory results.
  • APTA Physical Therapists & the Performance of Dry Needling

    Physical Therapists & the Performance of Dry Needling An Educational Resource Paper Produced by the APTA Department of Practice and APTA State Government Affairs January 2012 1 | Page Physical Therapists & the Performance of Dry Needling Forward The issue of whether the performance of dry needling (sometimes referred to as trigger point dry needling or intramuscular manual therapy) is within the professional and legal scope of physical therapist practice continues to be a question posed to state regulatory boards and agencies. The American Physical Therapy Association (APTA) created this document to provide background information for state chapters, regulatory entities, and providers who are dealing with this issue. APTA is the national professional association representing more than 77,000 physical therapists, physical therapist assistants, and students nationwide. Dry Needling by Physical Therapists Dry Needling is an invasive technique used by physical therapists (where allowed by state law) to treat myofascial pain that uses a dry needle, without medication or injection, which is inserted into areas of the muscle known as trigger points. A trigger point describes a taught band of skeletal muscle located within a larger muscle group. Trigger points can be tender to the touch and can refer pain to distant parts of the body. Physical therapists utilize dry needling with the goal of releasing/inactivating the trigger points and relieving pain. Preliminary research supports that dry needling improves pain control, reduces muscle tension, normalizes biochemical and electrical dysfunction of motor endplates, and facilitates an accelerated return to active rehabilitation. Numerous terms have been used in conjunction with dry needling. Some of the more common terms include trigger point manual therapy, trigger point dry needling, and intramuscular manual therapy.
  • Needle Acupuncture for Substance Use Disorders a Systematic Review

    Needle Acupuncture for Substance Use Disorders a Systematic Review

    NATIONAL DEFENSE RESEARCH INSTITUTE Needle Acupuncture for Substance Use Disorders A Systematic Review Sean Grant, Susanne Hempel, Ryan Kandrack, Aneesa Motala, Roberta M. Shanman, Marika Booth, Jeremy N. V. Miles, Whitney Dudley, Melony E. Sorbero Prepared for the Office of the Secretary of Defense Approved for public release; distribution unlimited For more information on this publication, visit www.rand.org/t/RR1030 Published by the RAND Corporation, Santa Monica, Calif. © Copyright 2015 RAND Corporation R® is a registered trademark. Limited Print and Electronic Distribution Rights This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited. Permission is given to duplicate this document for personal use only, as long as it is unaltered and complete. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial use. For information on reprint and linking permissions, please visit www.rand.org/pubs/permissions.html. The RAND Corporation is a research organization that develops solutions to public policy challenges to help make communities throughout the world safer and more secure, healthier and more prosperous. RAND is nonprofit, nonpartisan, and committed to the public interest. RAND’s publications do not necessarily reflect the opinions of its research clients and sponsors. Support RAND Make a tax-deductible charitable contribution at www.rand.org/giving/contribute www.rand.org Preface The Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury is interested in determining the efficacy and comparative effectiveness of integrative medicine approaches for psychological health conditions.
  • Dry Needling of Trigger Points for Myofascial Pain

    Dry Needling of Trigger Points for Myofascial Pain

    Medical Policy Joint Medical Policies are a source for BCBSM and BCN medical policy information only. These documents are not to be used to determine benefits or reimbursement. Please reference the appropriate certificate or contract for benefit information. This policy may be updated and is therefore subject to change. *Current Policy Effective Date: 5/1/21 (See policy history boxes for previous effective dates) Title: Dry Needling of Trigger Points for Myofascial Pain Description/Background Dry Needling Dry needling refers to a procedure in which a fine needle is inserted into the skin and muscle at a site of myofascial pain. The needle may be moved in an up-and-down motion, rotated, and/or left in place for as long as 30 minutes. The intent is to stimulate underlying myofascial trigger points, muscles, and connective tissues to manage myofascial pain. Dry needling may be performed with acupuncture needles or standard hypodermic needles but is performed without the injection of medications (e.g., anesthetics, corticosteroids). Dry needling is proposed to treat dysfunctions in skeletal muscle, fascia, and connective tissue; diminish persistent peripheral pain, and reduce impairments of body structure and function. The physiologic basis for dry needling depends on the targeted tissue and treatment objectives. The most studied targets are trigger points. Trigger points are discrete, focal, hyperirritable spots within a taut band of skeletal muscle fibers that produce local and/or referred pain when stimulated. Trigger points are associated with local ischemia and hypoxia, a significantly lowered pH, local and referred pain and altered muscle activation patterns.1 Trigger points can be visualized by magnetic resonance imaging and elastography.